NewsRx

Search our medical news database

Genocea Biosciences

Genocea Biosciences Appoints John Sorvillo Vice President of Business Development

Published in Health Business Week, August 14th, 2009

Genocea Biosciences, a leading vaccine discovery and development company, announced that John M. Sorvillo, Ph.D. has joined the company as Vice President of Business Development.

"It is a great pleasure to welcome John to our team," said Staph Leavenworth Bakali, Genocea's Chief Executive Officer. "John's extensive experience in business development and track record of success will be of great value to Genocea's partnering and business development activities."

"Genocea has developed one of the most exciting approaches to vaccine discovery and is accelerating vaccine development in multiple multi-billion dollar market segments," said Dr. Sorvillo. "I...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook